Published in TB and Outbreaks Week, July 11th, 2000
"The benefits of screening for latent Mycobacterium tuberculosis infection are unknown for most people, because screening has not been studied in clinical trials and preventive therapy has not been tested in all risk groups for whom it is recommended," D.N. Rose noted in the report.
For purposes of this study, Rose reviewed literature in the Medline database to determine the risks associated with tuberculosis.
"A Markov model was used to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week